22nd Century Group (XXII) Stock Falls 8% in a Week: What’s The Buzz?
The plant based biotech firm 22nd Century Group (NASDAQ:XXII), which is involved in reducing the harm from tobacco, has had a pretty tough time in the markets over the course of the past week. During the period, the 22nd Century stock has declined by as much as 8% and while the decline is considerable, it should be noted that there has been no news about the company in the past…